MedTrace Logo

Acute Intense Paraphilic Desire (DSM-V) Down-Regulation Via taVNS Neuro-Modulation [Transcutaneous Afferent Vagus Nerve] With Future Operative Implant Consideration

NCT05482412 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-07-20

No results posted yet for this study

Summary

Transcutaneous Afferent Vagus Nerve Stimulation \[taVNS\] is used to modulate persistent \& intense desire control amongst a specific participant group.

Testing Center Order of Deliver Number

Conditions

  • Desire; Sexual, Aversion
  • Paraphilia

Interventions

DEVICE

transcutaneous (superficial) afferent electrical nerve stimulation specific for vagus nerve

Direct superficial auricular sensory branch of Cr X \[Cranial Nerve Ten Vagus\]

Sponsors & Collaborators

  • Greg Thomas William Consultant Research, Queens University

    collaborator UNKNOWN

  • Irene Becker Consultant, Coaching Certification for Pain Management

    collaborator UNKNOWN

  • Susan Jones MD PhD

    collaborator UNKNOWN

  • Peter Martin BSc Forensic Psych, Masters in Education, JPH Internal Meds + Family Meds Rotation Teaching Assistant

    collaborator UNKNOWN

  • Kofi McNair Nyamekye B Eng. Op. Neuromod. Masters + 4th Yr Meds Student

    collaborator UNKNOWN

  • American University Of Montserrat

    lead OTHER

Principal Investigators

  • Athavan Gananathan, MD · CEO AUM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2024-06-15
Completion
2024-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05482412 on ClinicalTrials.gov